Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

MedImmune characterizes dual GLP-1/glucagon agonist for obesity

July 8, 2015

Strensiq receives first approval in Japan for hypophosphatasia

July 7, 2015

Versartis confirms removal of FDA partial hold on VRS-317 trial

July 7, 2015

ADA highlights: ultra-long acting GLP-1/glucagon agonists for type 2 diabetes and obesity

July 7, 2015

Dicerna Pharmaceuticals develops DsiRNAs targeting TTR for amyloidosis

July 6, 2015

ESN-364, an optimized NK3 receptor antagonist for sex-hormone disorders

July 6, 2015

First patient dosed in seliciclib trial in Cushing's disease

July 6, 2015

LG Life Sciences discloses a novel GPR120 agonist

July 6, 2015

Lilly's GLP-1 receptor agonist Trulicity Ateos approved in Japan

July 3, 2015

Ajinomoto divulges AJS-1669 for type 2 diabetes

July 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...